Passage Bio Inc share price logo

Passage Bio Inc Share Price

NASDAQ: PASG

Small Cap

$7.27

+0.32

(+4.60%)

as on

Passage Bio Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $6.95
    $7.42
    downward going graph

    4.40%

    Downside

    2.06%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.12
    $26.6
    downward going graph

    29.52%

    Downside

    265.89%

    Upside

    downward going graph

Passage Bio Inc share price movements today

Previous Close
$6.95
Open
$7.00
Volume
163.9K
Day's Low - High
$6.95 - $7.42
52 Week Low - High
$5.12 - $26.6

Passage Bio Inc Historical Returns

1 Month Return
0 %
3 Month Return
-13.73 %
1 Year Return
-52.43 %
3 Year Return
-78.01 %
5 Year Return
-97.97 %

Passage Bio Inc Stock Fundamentals & Key Indicators

Check Passage Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$22.3M

EPS (TTM)

-13.8067

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.18

Industry PE ratio

-3.947831325301205

P/B Ratio

0.1777

PEG Ratio

0

EBITDA

-52.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-88.27%

Passage Bio Inc Stock Valuation

Track how Passage Bio Inc P/E has moved over time to understand its valuation trends.

Passage Bio Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 16, 2025

Industry (-3.95x)

September 16, 2025

Today (0.18x)

September 16, 2025

Highest (0.00x)

September 16, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.18x

Passage Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Passage Bio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$22.3M-97.97%0.180.00%
BUY$61.1B251.26%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.2B47.46%28.0931.86%
BUY$59.6B0.6%14.131.37%

Stock Returns calculator for Passage Bio Inc Stock including INR - Dollar returns

The Passage Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Passage Bio Inc investment value today

Current value as on today

₹54,628

Returns

₹45,372

(-45.37%)

Returns from Passage Bio Inc Stock

₹50,240 (-50.24%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Passage Bio Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Passage Bio Inc. Average target price of $59.25

Passage Bio Inc Share Price Target

Get share price movements and forecasts by analysts on Passage Bio Inc.

What analysts predicted

87.73%UPSIDE

Target Price

$59.25

Current Price

$7.27

Analyzed by

11 Analysts

Target

$59.25

Passage Bio Inc target price $59.25, a slight upside of 87.73% compared to current price of $7.27. According to 11 analysts rating.

Passage Bio Inc Stock's Interest Amongst Investors

Search interest for Passage Bio Inc Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-4% versus previous 30 day period

Passage Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
5
-
-
-
3
-
-
Gross Profit
0
0
-1
5
0
0
0
1
0
0
Operating Income
-35
-25
-28
-18
-18
-17
-20
-14
-16
-10
EBITDA
-34
-24
-22
-17
-17
-16
-15
-13
-13
-10
Interest Expense
1
-
-
1
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-34
-23
-27
-16
-16
-15
-19
-12
-15
-9
Income Tax Expense
-1
0
0
3
0
-
-
-
-
-
Net Income
-32
-23
-27
-16
-16
-15
-19
-12
-15
-9
Net Profit Margin
0.00%
0.00%
0.00%
-283.46%
0.00%
0.00%
0.00%
-396.17%
0.00%
0.00%

Passage Bio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
0
0
-1
-3
-3
-3
Operating Income
-13
-37
-112
-185
-138
-100
-70
EBITDA
-7
-36
-111
-183
-132
-98
-61
Interest Expense
0
8
0
0
2
-
-
Depreciation
-
0
0
1
3
3
3
Income Before Tax
-12
-45
-112
-185
-136
-102
-64
Income Tax Expense
0
8
0
6
0
5
0
Net Income
-12
-45
-112
-185
-136
-102
-64
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Passage Bio Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-23
-27
-16
-16
-15
-19
-12
-15
-9
Operating Cash Flow
-17
-19
-19
-18
-13
-7
-8
-13
-6
Investing Cash Flow
13
22
7
25
1
14
13
39
0
Financing Cash Flow
0
-
0
8
0
-
0
-
0
Change in Cash
-3
3
-11
15
-12
7
5
25
-5

Passage Bio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-45
-112
-185
-136
-102
-64
Operating Cash Flow
-39
-80
-126
-118
-78
-47
Investing Cash Flow
-1
-172
-45
25
65
54
Financing Cash Flow
175
228
166
-1
0
8
Change in Cash
134
-23
-6
-94
-12
15

Global Institutional Holdings in Passage Bio Inc

Funds
Holdings
Orbimed Advisors, LLC
11.27%
Vestal Point Capital LP
9.77%
New Leaf Venture Partners, L.L.C.
4%
Erste Asset Management GmbH
3.94%
Vanguard Group Inc
3.32%

Insights on Passage Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 194.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 123.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, PASG stock has moved down by -13.7%

About Passage Bio Inc

passage bio, inc., a genetic medicines company, develops transformative therapies for rare monogenic central nervous system (cns) diseases. the company develops pbgm01, which utilizes a proprietary, aavhu68 capsid to deliver to the brain and peripheral tissues a functional glb1 gene encoding lysosomal acid beta-galactosidase (ãŸ-gal) for infantile gm1; pbft02, which utilizes an aav1 capsid to deliver to the brain a functional granulin, or grn, gene encoding progranulin for the treatment of ftd caused by a deficiency of progranulin; and pbkr03, which utilizes a proprietary, aavhu68 capsid to deliver to the brain and peripheral tissues a functional galc gene encoding the hydrolytic enzyme galactosylceramidase, for infantile krabbe disease. it has a strategic research collaboration with the trustees of the university of pennsylvania's gene therapy program; and collaboration agreement, and a development services and clinical supply agreement with catalent maryland, inc. the company was fou
OrganisationPassage Bio Inc
HeadquartersOne Commerce Square, Philadelphia, PA, United States, 19103
IndustryHealth Technology
CEODr. William Chou M.D.
E-voting on sharesClick here to vote

Key Management of Passage Bio Inc

Name

Title

Dr. Sue Browne Ph.D.

Chief Scientific Officer

Mr. Stuart M. Henderson

Chief Business Officer

Eden Fucci

Senior Vice President of Technical Operations

Dr. Karl Whitney Ph.D.

Senior Vice President of Global Regulatory Affairs

Dr. William Chou M.D.

President, CEO & Director

Ms. Kathleen Borthwick

Senior VP, CFO, Principal Financial Officer & Principal Accounting Officer

Mr. Edgar B. Cale Esq., J.D.

General Counsel & Company Secretary

FAQs

What is Passage Bio Inc share price today?

Passage Bio Inc share price today is $7.27 as on at the close of the market. Passage Bio Inc share today touched a day high of $7.42 and a low of $6.95.

What is the 52 week high and 52 week low for Passage Bio Inc share?

Passage Bio Inc share touched a 52 week high of $26.6 on and a 52 week low of $5.12 on . Passage Bio Inc stock price today i.e. is closed at $7.27,which is 72.67% down from its 52 week high and 41.88% up from its 52 week low.

What is Passage Bio Inc's market capitalisation today?

Passage Bio Inc market capitalisation is $0.00T as on .

How to invest in Passage Bio Inc Stock (PASG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Passage Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Passage Bio Inc Shares that will get you 0.2063 shares as per Passage Bio Inc share price of $7.27 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Passage Bio Inc Stock (PASG) from India?

Indian investors can start investing in Passage Bio Inc (PASG) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Passage Bio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Passage Bio Inc share’s latest price of $7.27 as on September 17, 2025 at 1:29 am IST, you will get 1.3755 shares of Passage Bio Inc. Learn more about fractional shares .

What are the returns that Passage Bio Inc has given to Indian investors in the last 5 years?

Passage Bio Inc stock has given -97.97% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?